25144449|t|Safety of low-dose aspirin in endovascular treatment for intracranial atherosclerotic stenosis.
25144449|a|OBJECTIVES: To evaluate the safety of low-dose aspirin plus clopidogrel versus high-dose aspirin plus clopidogrel in prevention of vascular risk within 90 days of duration of dual antiplatelet therapy in patients treated with intracranial endovascular treatment. METHODS: From January 2012 to December 2013, this prospective and observational study enrolled 370 patients with symptomatic intracranial atherosclerotic stenosis of >=70% with poor collateral undergoing intracranial endovascular treatment. Antiplatelet therapy consists of aspirin, at a low-dose of 100 mg or high-dose of 300 mg daily; clopidogrel, at a dose of 75 mg daily for 5 days before endovascular treatment. The dual antiplatelet therapy continued for 90 days after intervention. The study endpoints include acute thrombosis, subacute thrombosis, stroke or death within 90 days after intervention. RESULTS: Two hundred and seventy three patients received low-dose aspirin plus clopidogrel and 97 patients received high-dose aspirin plus clopidogrel before intracranial endovascular treatment. Within 90 days after intervention, there were 4 patients (1.5%) with acute thrombosis, 5 patients (1.8%) with subacute thrombosis, 17 patients (6.2%) with stroke, and 2 death (0.7%) in low-dose aspirin group, compared with no patient (0%) with acute thrombosis, 2 patient (2.1%) with subacute thrombosis, 6 patients (6.2%) with stroke, and 2 death (2.1%) in high-dose aspirin group, and there were no significant difference in all study endpoints between two groups. CONCLUSION: Low-dose aspirin plus clopidogrel is comparative in safety with high-dose aspirin plus clopidogrel within 90 days of duration of dual antiplatelet therapy in patients treated with intracranial endovascular treatment.
25144449	19	26	aspirin	Chemical	MESH:D001241
25144449	57	94	intracranial atherosclerotic stenosis	Disease	MESH:D002537
25144449	143	150	aspirin	Chemical	MESH:D001241
25144449	156	167	clopidogrel	Chemical	MESH:D000077144
25144449	185	192	aspirin	Chemical	MESH:D001241
25144449	198	209	clopidogrel	Chemical	MESH:D000077144
25144449	276	288	antiplatelet	Chemical	-
25144449	300	308	patients	Species	9606
25144449	322	334	intracranial	Disease	MESH:D001932
25144449	458	466	patients	Species	9606
25144449	484	521	intracranial atherosclerotic stenosis	Disease	MESH:D002537
25144449	563	575	intracranial	Disease	MESH:D001932
25144449	600	612	Antiplatelet	Chemical	-
25144449	633	640	aspirin	Chemical	MESH:D001241
25144449	696	707	clopidogrel	Chemical	MESH:D000077144
25144449	785	797	antiplatelet	Chemical	-
25144449	882	892	thrombosis	Disease	MESH:D013927
25144449	903	913	thrombosis	Disease	MESH:D013927
25144449	915	921	stroke	Disease	MESH:D020521
25144449	925	930	death	Disease	MESH:D003643
25144449	1005	1013	patients	Species	9606
25144449	1032	1039	aspirin	Chemical	MESH:D001241
25144449	1045	1056	clopidogrel	Chemical	MESH:D000077144
25144449	1064	1072	patients	Species	9606
25144449	1092	1099	aspirin	Chemical	MESH:D001241
25144449	1105	1116	clopidogrel	Chemical	MESH:D000077144
25144449	1124	1136	intracranial	Disease	MESH:D001932
25144449	1209	1217	patients	Species	9606
25144449	1236	1246	thrombosis	Disease	MESH:D013927
25144449	1250	1258	patients	Species	9606
25144449	1280	1290	thrombosis	Disease	MESH:D013927
25144449	1295	1303	patients	Species	9606
25144449	1316	1322	stroke	Disease	MESH:D020521
25144449	1330	1335	death	Disease	MESH:D003643
25144449	1355	1362	aspirin	Chemical	MESH:D001241
25144449	1387	1394	patient	Species	9606
25144449	1411	1421	thrombosis	Disease	MESH:D013927
25144449	1425	1432	patient	Species	9606
25144449	1454	1464	thrombosis	Disease	MESH:D013927
25144449	1468	1476	patients	Species	9606
25144449	1489	1495	stroke	Disease	MESH:D020521
25144449	1503	1508	death	Disease	MESH:D003643
25144449	1529	1536	aspirin	Chemical	MESH:D001241
25144449	1649	1656	aspirin	Chemical	MESH:D001241
25144449	1662	1673	clopidogrel	Chemical	MESH:D000077144
25144449	1714	1721	aspirin	Chemical	MESH:D001241
25144449	1727	1738	clopidogrel	Chemical	MESH:D000077144
25144449	1774	1786	antiplatelet	Chemical	-
25144449	1798	1806	patients	Species	9606
25144449	1820	1832	intracranial	Disease	MESH:D001932
25144449	Negative_Correlation	MESH:D001241	MESH:D001932
25144449	Negative_Correlation	MESH:D000077144	MESH:D002537
25144449	Negative_Correlation	MESH:D000077144	MESH:D001932
25144449	Positive_Correlation	MESH:D001241	MESH:D013927
25144449	Cotreatment	MESH:D000077144	MESH:D001241
25144449	Negative_Correlation	MESH:D001241	MESH:D002537
25144449	Association	MESH:D001241	MESH:D020521

